Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1521988
                    [Title] => Varenicline facilitates gradual smoking cessation
                    [Summary] => 
A 24-week course of Varenicline improved quit rates among smokers who were unwilling or unable to stop smoking abruptly but preferred to gradually reduce their use of cigarettes, a study showed.

                    [DatePublished] => 2015-11-14 09:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 67509
                    [Title] => BFAD warns public vs anti-smoking drug
                    [Summary] => 
            
                    [DatePublished] => 2008-06-13 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Metro
                    [SectionUrl] => metro
                    [URL] => 
                )

        )

)

VARENICLINE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1521988
                    [Title] => Varenicline facilitates gradual smoking cessation
                    [Summary] => 
A 24-week course of Varenicline improved quit rates among smokers who were unwilling or unable to stop smoking abruptly but preferred to gradually reduce their use of cigarettes, a study showed.

                    [DatePublished] => 2015-11-14 09:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 67509
                    [Title] => BFAD warns public vs anti-smoking drug
                    [Summary] => 
            
                    [DatePublished] => 2008-06-13 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Metro
                    [SectionUrl] => metro
                    [URL] => 
                )

        )

)

abtest

Varenicline facilitates gradual smoking cessation

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | November 14, 2015 - 9:00am

A 24-week course of Varenicline improved quit rates among smokers who were unwilling or unable to stop smoking abruptly but preferred to gradually reduce their use of cigarettes, a study showed.

Opinion

BFAD warns public vs anti-smoking drug

By Sheila Crisostomo | June 13, 2008 - 12:00am

Metro